| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |